不能平静 发表于 2025-3-25 03:47:19
https://doi.org/10.1007/978-94-007-6149-0ncertainty; (D) uniqueness and competition in discovery; and (E) implications on management and policy. We hope that the discussion of these topics will deepen our understandings of pharmaceutical innovations.组成 发表于 2025-3-25 09:58:51
http://reply.papertrans.cn/29/2831/283084/283084_22.pngSarcoma 发表于 2025-3-25 12:38:24
Sources of Innovation of Drug Discovery in Japan and Its Implications,ncertainty; (D) uniqueness and competition in discovery; and (E) implications on management and policy. We hope that the discussion of these topics will deepen our understandings of pharmaceutical innovations.JIBE 发表于 2025-3-25 16:16:07
http://reply.papertrans.cn/29/2831/283084/283084_24.png联想记忆 发表于 2025-3-25 20:01:03
http://reply.papertrans.cn/29/2831/283084/283084_25.pngInelasticity 发表于 2025-3-26 00:39:48
http://reply.papertrans.cn/29/2831/283084/283084_26.png荣幸 发表于 2025-3-26 05:22:31
Rosuvastatin (Crestor),otency, together with atorvastatin (Lipitor). Relative to the earlier statins, rosuvastatin was a very late entrant into the market. However, Crestor became a highly successful global blockbuster drug. In the global competition to discover synthetic statins with stronger efficacy than the statins frPresbycusis 发表于 2025-3-26 11:14:46
Leuprorelin (Leuplin, Lupron, Viadur), of luteinizing hormone-releasing hormone (LH-RH). Researchers at Takeda Pharmaceutical synthesized the active ingredient using the characterized primary structure of thyrotropin-releasing hormone (TRH) and LH-RH as a model, both discovered within academia. Their research was aided partly by luck an眨眼 发表于 2025-3-26 16:41:47
http://reply.papertrans.cn/29/2831/283084/283084_29.pngChivalrous 发表于 2025-3-26 17:37:46
http://reply.papertrans.cn/29/2831/283084/283084_30.png